Hamburg in Germany, Hinxton in the UK, Grenoble in France and Monterotondo in Italy.
Sartorius has joined the Corporate Partnership Program, EMBL’ s platform for fostering advanced training collaboration and activities designed to connect industry to academia. The Corporate Partnership Program includes initiatives such as creating training courses, sponsoring conferences, organizing workshops for professionals and young scientists at the EMBL International Center for Advanced Training, EICAT, which offers numerous courses and conferences each year. In addition, Sartorius will also provide long-term support to EMBL’ s school education program by funding travel bursaries each year for teachers to attend courses run by EMBL’ s Learning Laboratory for the Life Sciences, ELLS.
Backing this well-known research institution, Sartorius is offering its expertise to enhance scientific education and practice.“ By focusing on professional training at all levels, and ensuring that the next generation of young talent has access to the latest knowledge, we aim to support the scientific community to reach its maximum potential,” stated Karen Storm, Vice President of Marketing of the Lab Products and Services Division at Sartorius.
India has 1022 biotech start-ups; $ 2.8 billion in biotechled investments: ABLE’ s white paper
The Indian biotech ecosystem is booming with 1022 companies and over $ 2.8 billion( Rs 18,700 crore) investments in five years from 2012 to 2016, according to a study,“ India’ s Biotech Start-Ups Ecosystem” by the Association of Biotechnology Led Enterprises( ABLE).
Bangalore is the biotech start-up capital of India hosting 190 of the 1022 biotech start-ups formed in the last five years. National Capital Region( NCR) ranks second with 164 startups followed closely by Mumbai( 163) and Hyderabad( 160).
“ This is good news and we are aiming to double this number with the ABLE Start-Ups 2020 initiative to take the count to 2020 companies by the year 2020 and $ 5 billion of investments,” said Dr PM Murali, president, ABLE and CEO, Evolva India.
“ ABLE takes pride in initiating a‘ mentoring’ cell of senior industry leaders to guide the next generation of biotech entrepreneurs and create the world’ s most vibrant biotech ecosystem in India,” added Dr Kiran Mazumdar-Shaw, honorary chairman, ABLE and CMD, Biocon. Many senior ABLE members are already mentoring startups in their individual capacities so far and these efforts will be further strengthened.
Of the 1022 new start-ups, biotech
BIOVOICENEWS. COM 57